calendar
4,732 catalysts · 4,590 phase readout · 2,336 8k filing · 284 earnings · 172 phase 2 completion · 136 pdufa · 73 phase 1 completion
next 91 dayslessmore
MonWedFri
4,732 catalysts · 4,590 phase readout · 2,336 8k filing · 284 earnings · 172 phase 2 completion · 136 pdufa · 73 phase 1 completion
Sponsor: National Institute on Drug Abuse (NIDA). Phase: EARLY_PHASE1. Conditions: Normal Physiology
Sponsor: Nikolaj Frost MD. Phase: PHASE4. Conditions: Non-Small Cell Lung Cancer Metastatic
Sponsor: KK Women's and Children's Hospital. Phase: . Conditions: Pediatrics, Intensive Care Unit, Critical Illness
Sponsor: Jiangxi Qingfeng Pharmaceutical Co. Ltd.. Phase: PHASE3. Conditions: Epilepsy, Focal
Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Consciousness Disorders, Disorders of Consciousness Due to Severe Brain Injury
Sponsor: Kathmandu University School of Medical Sciences. Phase: NA. Conditions: Blood Loss, Postoperative, Blood Loss, Surgical, Femoral Fracture, Tibial Fracture
Sponsor: Beijing Tiantan Hospital. Phase: NA. Conditions: Herpes Zoster, Pain
Sponsor: Catholic University of the Sacred Heart. Phase: NA. Conditions: Obesity (BMI > 35)
Sponsor: Central Hospital, Nancy, France. Phase: . Conditions: Antisynthetase Syndrome
Sponsor: Bayer. Phase: PHASE2. Conditions: High-Risk Localized Prostate Cancer
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Activated PI3K Delta Syndrome
Sponsor: University of Stirling. Phase: NA. Conditions: Health Behavior
Sponsor: Ohio State University. Phase: NA. Conditions: Suicide Prevention
Sponsor: Charite University, Berlin, Germany. Phase: NA. Conditions: Psychosis, Psychotic Disorders, Primary Psychotic Disorders, Schizophrenia Spectrum Disorders, Schizophrenia, Schizoaffective Disorder
Sponsor: Boston Children's Hospital. Phase: . Conditions: Intestinal Failure, Hypoglycemia, Hyperglycemia
Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University. Phase: . Conditions: Glaucoma, OCTA, Choroid
Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Advanced Melanoma, Recurrent Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver, Metastatic Malignant Neoplasm in the Lung, Recurrent Colorectal Carcinoma, Resectable Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7, Stage IVA Colorectal Cancer AJCC v7, Stage IVB Colorectal Cancer AJCC v7
Sponsor: Heartfelt Technologies. Phase: . Conditions: Heart Failure
Sponsor: The First Affiliated Hospital with Nanjing Medical University. Phase: NA. Conditions: Pulsed Dye Laser, Rosacea
Sponsor: Ho-Won Lee. Phase: NA. Conditions: Parkinson's Disease, Depression
Sponsor: Chang Gung Memorial Hospital. Phase: NA. Conditions: Communication
Sponsor: Tel Aviv University. Phase: NA. Conditions: Major Depressive Disorder (MDD)
Sponsor: Medical University of Graz. Phase: NA. Conditions: Tooth Loss
Sponsor: University of Miami. Phase: . Conditions: Diabetes Mellitus, Type 1
Sponsor: Servicio de Salud Metropolitano Sur Oriente. Phase: PHASE2. Conditions: Rectal Cancer
Sponsor: Amgen. Phase: PHASE1. Conditions: Prostate Cancer
Sponsor: Johns Hopkins University. Phase: PHASE2. Conditions: Food Hypersensitivity
Sponsor: Methodist Health System. Phase: . Conditions: Frailty, Sarcopenia, COVID-19
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Healthy Adult Trial Participants
Sponsor: St. Pölten University of Applied Sciences. Phase: NA. Conditions: Osteo Arthritis Knee
Sponsor: Ain Shams University. Phase: NA. Conditions: We Are Studying the Effects of Caudal Dexamethasone in Neonates Undergoing Inguinal Hernia Repair
Sponsor: University of Pennsylvania. Phase: PHASE1. Conditions: Brain Tumor, Primary, Brain Tumor, Recurrent
Sponsor: Xinqiao Hospital of Chongqing. Phase: EARLY_PHASE1. Conditions: EBV-associated Tumors
Sponsor: Fauji Foundation Hospital. Phase: . Conditions: Traumatic Spinal Cord Injury
Sponsor: Atom Therapeutics Co., Ltd. Phase: PHASE1. Conditions: Gout Chronic, Gout, DDI (Drug-Drug Interaction)
Sponsor: Jiangsu HengRui Medicine Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumor
Sponsor: Berivan Beril Kılıç. Phase: . Conditions: Multiple Sclerosis, Pelvic Floor Dysfunction
Sponsor: Massachusetts General Hospital. Phase: EARLY_PHASE1. Conditions: Arginine Vasopressin Deficiency, Oxytocin Deficiency, Pediatric Disease, Hypopituitarism
Sponsor: Poitiers University Hospital. Phase: NA. Conditions: Oxygen Inhalation Therapy Endoscopy
Sponsor: Daniel B. F. Saris. Phase: PHASE1. Conditions: Cartilage Defect
Sponsor: Yonsei University. Phase: PHASE2. Conditions: Carcinoma, Small Cell Lung
Sponsor: Akyso Therapeutics, LLC. Phase: PHASE1. Conditions: Opioid Use Disorder
Sponsor: Amgen. Phase: PHASE1. Conditions: Atopic Dermatitis
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Decision Support System, Outcome
Sponsor: University of Alberta. Phase: PHASE1. Conditions: Migraine, Headache
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Osteogenesis Imperfecta, Short Stature
Sponsor: Universitaire Ziekenhuizen KU Leuven. Phase: . Conditions: Cerebral Palsy (CP), Typically Developing Children
Sponsor: National Institute on Drug Abuse (NIDA). Phase: PHASE2. Conditions: Addiction, Alcohol Use Disorder
Sponsor: St George's, University of London. Phase: NA. Conditions: Spinal Cord Injuries